Skip to main content
. Author manuscript; available in PMC: 2014 Jul 11.
Published in final edited form as: Am J Manag Care. 2013 Mar 1;19(3):e85–e92.

Figure 2.

Figure 2

Categorical Measure of 80% or Greater Adherence to Oral Hypoglycemic Agents (Upper Panel) and to Antidepressants (Bottom Panel), Assessed With Self-Report and Electronic Monitoring at Baseline, 6, and 12 Weeks (n = 180)

MEMS indicates Medication Event Monitoring System.

HHS Vulnerability Disclosure